Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
Key points
اہم نکات
मुख्य बातें
- Moderna has raised its outlook for 2026, saying its newer vaccines are starting to gain real traction, CNBC reports.
- The company's chief executive said demand for its latest shots is building, giving Moderna more confidence about the year ahead.
- The improved forecast comes as the vaccine maker works to move beyond its Covid-era boom and build a broader business.
- Moderna has raised its outlook for 2026, saying its newer vaccines are starting to gain real traction, CNBC reports.
- The company's chief executive said demand for its latest shots is building, giving Moderna more confidence about the year ahead.
- The improved forecast comes as the vaccine maker works to move beyond its Covid-era boom and build a broader business.
- Moderna has raised its outlook for 2026, saying its newer vaccines are starting to gain real traction, CNBC reports.
- The company's chief executive said demand for its latest shots is building, giving Moderna more confidence about the year ahead.
- The improved forecast comes as the vaccine maker works to move beyond its Covid-era boom and build a broader business.
Moderna has raised its outlook for 2026, saying its newer vaccines are starting to gain real traction, CNBC reports. The company's chief executive said demand for its latest shots is building, giving Moderna more confidence about the year ahead. The improved forecast comes as the vaccine maker works to move beyond its Covid-era boom and build a broader business. Investors will now watch whether the momentum holds, and whether the newer products can carry growth in the years to come.
Moderna has raised its outlook for 2026, saying its newer vaccines are starting to gain real traction, CNBC reports. The company's chief executive said demand for its latest shots is building, giving Moderna more confidence about the year ahead. The improved forecast comes as the vaccine maker works to move beyond its Covid-era boom and build a broader business. Investors will now watch whether the momentum holds, and whether the newer products can carry growth in the years to come.
Moderna has raised its outlook for 2026, saying its newer vaccines are starting to gain real traction, CNBC reports. The company's chief executive said demand for its latest shots is building, giving Moderna more confidence about the year ahead. The improved forecast comes as the vaccine maker works to move beyond its Covid-era boom and build a broader business. Investors will now watch whether the momentum holds, and whether the newer products can carry growth in the years to come.
Most read
سب سے زیادہ پڑھی گئی
सबसे ज़्यादा पढ़ी गई
- Loading...
Get news in your inbox
خبریں اپنے ان باکس میں حاصل کریں
खबरें अपने इनबॉक्स में पाएं
One email when new stories are published. No spam, unsubscribe anytime.
نئی خبریں شائع ہونے پر ایک ای میل۔ کوئی سپیم نہیں، کسی بھی وقت ان سبسکرائب کریں۔
नई खबरें प्रकाशित होने पर एक ईमेल। कोई स्पैम नहीं, कभी भी अनसब्सक्राइब करें।